Download video

Implementing the AMA MAP™ Hypertension Program at Grace Health

44 views

American Medical Association (AMA)

3 weeks ago

Implementing the AMA MAP™ Hypertension Program at Grace Health

Implementing the AMA MAP™ Hypertension Program at Grace Health

The potential of MDM2 inhibitors in MPNs: past and ongoing studies of navtemadlin
9:54
The potential of MDM2 inhibitors in MPNs: past and ongoing studies of navtemadlin
by VJHemOnc – Video Journal of Hematology \& HemOnc
#188 Orthostatic Hypotension Part 2: Gray Matters Segment
40:01
#188 Orthostatic Hypotension Part 2: Gray Matters Segment
by Core IM
202510141508
3:21
202510141508
by Informatics
SAMPLING RM2 2025
28:30
SAMPLING RM2 2025
by Preventive and Community Medicine Department
Bodyweight-Based Continuous IV Medication Calculations
28:45
Bodyweight-Based Continuous IV Medication Calculations
by Prepare RN
Level2 Why Timing Matters: Taking Migraine Headache Meds Early
1:24
Level2 Why Timing Matters: Taking Migraine Headache Meds Early
by Health EnSuite
Prognostication Updated - Part 2
32:41
Prognostication Updated - Part 2
by Holistic Palliative and Pain
SIH25212-Solution
6:05
SIH25212-Solution
by PlayMetrices
FRCPath Haem Part 2 Exam: Last Minute Advice
57:10
FRCPath Haem Part 2 Exam: Last Minute Advice
by Haematology, Morphology, FRCPath Exams
ACC 25 Late-Breaking Discussion: ADVANCE-HTN: Lorundrostat in Pts with Uncontrolled Hypertension
17:27
ACC 25 Late-Breaking Discussion: ADVANCE-HTN: Lorundrostat in Pts with Uncontrolled Hypertension
by Radcliffe Cardiology
PSA Greater Than 0.2 After 6-12 Months of Treatment for mHSPC Intensified by ARPI
9:10
PSA Greater Than 0.2 After 6-12 Months of Treatment for mHSPC Intensified by ARPI
by GU Oncology Now
Dr. Steven Nissen and Dr. Mohammad Hossain on ALPACA Phase 2 Trial of Lepodisiran
7:26
Dr. Steven Nissen and Dr. Mohammad Hossain on ALPACA Phase 2 Trial of Lepodisiran
by FITsOnTheGO
MAP2 Is Recruited to Stationary and Moving Rab6 Vesicles in the Presence of KIF5
0:18
MAP2 Is Recruited to Stationary and Moving Rab6 Vesicles in the Presence of KIF5
by Cell Press
PHẦN 2: ÁO GIÁP BAO VI NANG \& TẤM KHIÊN HOẠT ĐỘ NƯỚC –DẤU ẤN KHÁC BIỆT CỦA MEN VI SINH LACTOMIN PLUS
3:15
PHẦN 2: ÁO GIÁP BAO VI NANG \& TẤM KHIÊN HOẠT ĐỘ NƯỚC –DẤU ẤN KHÁC BIỆT CỦA MEN VI SINH LACTOMIN PLUS
by Dược phẩm Úc Châu - Austrapharm
ACC 2025: The ALPACA Phase 2 Trial
2:55
ACC 2025: The ALPACA Phase 2 Trial
by Radcliffe Cardiology
Mod2 review part2 10 13 25
1:02:36
Mod2 review part2 10 13 25
by AC Healthconcepts IV
Ep. 32: Assessing the impact of AI in medicine
26:39
Ep. 32: Assessing the impact of AI in medicine
by Permanente Medicine
PerfWeb 105 Day 2: Hemoglobin and DO₂ in Perfusion
1:06:46
PerfWeb 105 Day 2: Hemoglobin and DO₂ in Perfusion
by PerfWeb
Foundations for Improving Hypertension Management (2\/3)
55:25
Foundations for Improving Hypertension Management (2\/3)
by CareOregon
Hypercalcaemia Made Easy: PTH-Dependent vs Independent Explained
13:01
Hypercalcaemia Made Easy: PTH-Dependent vs Independent Explained
by Tutorials by Kristeen Barker
GR02T: A Forecasting Tool to Detect Environments Favorable for Hail and Severe Convection
53:24
GR02T: A Forecasting Tool to Detect Environments Favorable for Hail and Severe Convection
by WMO-CGMS Virtual Laboratory